Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04793334 · ClinicalTrials.gov registry record
Underlying Mechanisms of Obesity-induced Obstructive Sleep Apnea
A clinical trial of Obesity and Obstructive Sleep Apnea, sponsored by Brandon Nokes.
- Completed
- Registry status
- 106
- Enrollment target
- 1
- Study location
NCT04793334 is a study of Obesity and Obstructive Sleep Apnea that has completed, run by Brandon Nokes. The registered enrollment target is 106 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04793334, a study of Obesity and Obstructive Sleep Apnea, has completed, sponsored by Brandon Nokes.
- COMPLETED
- Registry status
- 106 participants
- Enrollment target
- 1
- Study location
Study Summary
Obesity is a common risk factor for the development of obstructive sleep apnea. However, not all subjects with obesity develop obstructive sleep apnea. This study will attempt to determine the mechanistic drivers between obesity and obstructive sleep apnea.
Conditions Studied
Interventions
- PROCEDURE sleeve gastectomy
Study Locations (1)
California
- UCSD - Altman Clinical Research Institute (ACTRI) - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2021-03-20 |
| Est. Completion | 2025-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04793334
The ClinicalTrials.gov registry entry for NCT04793334 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (87% lower). The listed sponsor is Brandon Nokes, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which sleeve gastectomy is the first listed.
NCT04793334 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04793334 about?
NCT04793334 is a clinical study titled "Underlying Mechanisms of Obesity-induced Obstructive Sleep Apnea". Obesity is a common risk factor for the development of obstructive sleep apnea. However, not all subjects with obesity develop obstructive sleep apnea. This study will attempt to determine the mechanistic drivers between obesity and obstructive sleep apnea.
What is the current status of trial NCT04793334?
This trial is currently completed. The enrollment target is 106 participants. The study started on 2021-03-20. Estimated completion is 2025-05-31.
What conditions does trial NCT04793334 study?
This clinical trial studies the following conditions: Obesity, Obstructive Sleep Apnea.
What interventions are being tested in trial NCT04793334?
The interventions under investigation include: sleeve gastectomy (PROCEDURE).
Who is sponsoring clinical trial NCT04793334?
This trial is sponsored by Brandon Nokes, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04793334 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.